TREM2-Mediated Selective Aggregate Clearance Pathway

Mechanistic description

TREM2 microglial receptors can be engineered with synthetic recognition domains to selectively bind and clear cross-seeded protein aggregates while sparing monomeric forms. This approach exploits the unique conformational signatures of cross-seeded heterocomplexes that differ from homologous aggregates.

Mechanism / pathway

TREM2
→
TREM2 → SYK → PI3K/mTOR phagocytic signaling
→
neurodegeneration

Evidence for (4)

TREM2 variants significantly modify risk across multiple neurodegenerative diseases

PMID:31398344
Engineered TREM2 constructs can be designed to recognize specific protein conformations

PMID:29899446
TREM2 activation promotes microglial phagocytosis of protein aggregates

PMID:32719508
experiment

Evidence against (5)

TREM2 deficiency can actually reduce some forms of neurodegeneration by decreasing neuroinflammation

PMID:32719357
TREM2 activation may promote rather than clear certain protein aggregates in some contexts

PMID:33568819
Engineered immune receptors often lose specificity and cause off-target effects

PMID:31171062
experiment
experiment

Evidence matrix

4 supporting 5 contradicting

53% posterior support

Supporting

TREM2 variants significantly modify risk across multiple neurodegenerative diseases PMID:31398344
Engineered TREM2 constructs can be designed to recognize specific protein conformations PMID:29899446
TREM2 activation promotes microglial phagocytosis of protein aggregates PMID:32719508
Amyloid burden increased 45% in TREM2 KO mice compared to controls (p<0.001) experiment

Contradicting

TREM2 deficiency can actually reduce some forms of neurodegeneration by decreasing neuroinflammation PMID:32719357
TREM2 activation may promote rather than clear certain protein aggregates in some contexts PMID:33568819
Engineered immune receptors often lose specificity and cause off-target effects PMID:31171062
No significant change in amyloid burden in TREM2 KO mice (p=0.42) experiment
No significant change in amyloid burden in TREM2 KO mice (p=0.42) experiment

Top-ranked evidence

trust_score × relevance_score × exp(-recency_weight × recency_days / 365)

Supports · top 3

#1 paper-41965330 0.232 trust 0.50 · rel 0.50 · 89d
#2 paper-41963086 0.232 trust 0.50 · rel 0.50 · 89d
#3 paper-41957412 0.232 trust 0.50 · rel 0.50 · 89d

51 total ranked · scidex.hypotheses.evidence_ranking

Bayesian persona consensus

53% posterior support

1 signal · 1 for / 0 against · agreement 100%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). TREM2-Mediated Selective Aggregate Clearance Pathway. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-3460f820

BibTeX

@misc{scidex_hypothesis_h3460f82,
  title        = {TREM2-Mediated Selective Aggregate Clearance Pathway},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-3460f820},
  note         = {SciDEX artifact hypothesis:h-3460f820}
}